Literature DB >> 11249958

Distinct effect of pregnenolone sulfate on NMDA receptor subtypes.

M Ceccon1, G Rumbaugh, S Vicini.   

Abstract

Using rapid agonist applications to transfected HEK-293 cells, we investigated pregnenolone sulfate (PS) effects on deactivation and desensitization of recombinant NMDA receptors subtypes. PS prolonged the deactivation of responses produced by brief applications of L-glutamate with all subunit combinations tested. The action of PS was larger on NR1a/NR2A than on NR1a/NR2B channels. PS slowed the rate of macroscopic desensitization of the responses with all subunit combinations tested. In contrast, PS had little effect on current rise time and had much reduced action on responses with L-cysteate, a low affinity agonist. Our results suggest that PS decreases agonist unbinding. However, this action is counteracted by decreased desensitization. Since desensitization produces slow deactivating components, particularly with NR1a/NR2B receptors, this underlies the decreased PS effect with these subtypes. Indeed PS action was mainly observed on the fast component of deactivation. Furthermore, prolongation of NR1a/NR2A responses was similar to that of responses from NR1b/NR2B receptor, a subtype characterized by reduced desensitization. PS prolongation of evoked NMDA receptor mediated synaptic currents from cortical neuronal primary culture(s) was not significantly different from that of responses with NR1a/NR2B receptors indicating that native receptors in these neurons comprised at least some heteromeric combinations of these two subunits.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11249958     DOI: 10.1016/s0028-3908(00)00197-0

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  14 in total

Review 1.  Fast nongenomic effects of steroids on synaptic transmission and role of endogenous neurosteroids in spinal pain pathways.

Authors:  Rémy Schlichter; Anne Florence Keller; Mathias De Roo; Jean-Didier Breton; Perrine Inquimbert; Pierrick Poisbeau
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

Review 2.  Glutamate receptor ion channels: structure, regulation, and function.

Authors:  Stephen F Traynelis; Lonnie P Wollmuth; Chris J McBain; Frank S Menniti; Katie M Vance; Kevin K Ogden; Kasper B Hansen; Hongjie Yuan; Scott J Myers; Ray Dingledine
Journal:  Pharmacol Rev       Date:  2010-09       Impact factor: 25.468

3.  Positive allosteric modulators that target NMDA receptors rectify loss-of-function GRIN variants associated with neurological and neuropsychiatric disorders.

Authors:  Weiting Tang; Ding Liu; Stephen F Traynelis; Hongjie Yuan
Journal:  Neuropharmacology       Date:  2020-07-24       Impact factor: 5.250

4.  Low concentrations of neuroactive steroids alter kinetics of [3H]ifenprodil binding to the NMDA receptor in rat frontal cortex.

Authors:  Tobias Johansson; Per-Anders Frändberg; Fred Nyberg; Pierre Le Grevès
Journal:  Br J Pharmacol       Date:  2005-11       Impact factor: 8.739

5.  Mechanistic Insight into NMDA Receptor Dysregulation by Rare Variants in the GluN2A and GluN2B Agonist Binding Domains.

Authors:  Sharon A Swanger; Wenjuan Chen; Gordon Wells; Pieter B Burger; Anel Tankovic; Subhrajit Bhattacharya; Katie L Strong; Chun Hu; Hirofumi Kusumoto; Jing Zhang; David R Adams; John J Millichap; Slavé Petrovski; Stephen F Traynelis; Hongjie Yuan
Journal:  Am J Hum Genet       Date:  2016-11-10       Impact factor: 11.025

6.  Bidirectional Effect of Pregnenolone Sulfate on GluN1/GluN2A N-Methyl-D-Aspartate Receptor Gating Depending on Extracellular Calcium and Intracellular Milieu.

Authors:  Divyan A Chopra; Daniel T Monaghan; Shashank M Dravid
Journal:  Mol Pharmacol       Date:  2015-07-10       Impact factor: 4.436

Review 7.  NMDA receptors: linking physiological output to biophysical operation.

Authors:  Gary J Iacobucci; Gabriela K Popescu
Journal:  Nat Rev Neurosci       Date:  2017-03-17       Impact factor: 34.870

Review 8.  Neurosteroid regulation of central nervous system development.

Authors:  Synthia H Mellon
Journal:  Pharmacol Ther       Date:  2007-06-16       Impact factor: 12.310

9.  Discovery of Dihydropyrrolo[1,2-a]pyrazin-3(4H)-one-Based Second-Generation GluN2C- and GluN2D-Selective Positive Allosteric Modulators (PAMs) of the N-Methyl-d-Aspartate (NMDA) Receptor.

Authors:  Matthew P Epplin; Ayush Mohan; Lynnea D Harris; Zongjian Zhu; Katie L Strong; John Bacsa; Phuong Le; David S Menaldino; Stephen F Traynelis; Dennis C Liotta
Journal:  J Med Chem       Date:  2020-07-06       Impact factor: 7.446

Review 10.  Positive and Negative Allosteric Modulators of N-Methyl-d-aspartate (NMDA) Receptors: Structure-Activity Relationships and Mechanisms of Action.

Authors:  Erica S Burnell; Mark Irvine; Guangyu Fang; Kiran Sapkota; David E Jane; Daniel T Monaghan
Journal:  J Med Chem       Date:  2018-03-05       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.